ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients
August 05, 2021A large clinical trial conducted worldwide shows that treating moderately ill hospitalized COVID-19 patients with a full-dose blood thinner reduced their need for organ support, such as mechanical ventilation, and improved their chances . -
NIH launches antithrombotics trials in COVID-19 patients
September 16, 2020The adaptive Phase III trials will assess whether various types and doses of blood thinners can prevent COVID-19 patients forming potentially fatal blood clots. -
Aplagon and Cadila Pharmaceuticals to develop APAC first-in-class antithrombotics targeting vascular
September 22, 2017A new Aplagon-Cadila Pharmaceuticals partnership is focused on APAC first-in-class antithrombotics, with clinical trials expected to commence in 2019.
Pharma Sources Insight January 2025
